Search Tag: Cancer

IMAGING Management

Navidea Lymphoseek® Gains FDA Approval

2013 16 Apr

Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek® (technetium Tc 99m tilmanocept) Injection, which is indicated for use in lymphatic mapping procedures to assist in the localisation of lymph nodes draining a primary... Read more

Executive Health Management

Advances in Molecular Testing Offer New Hope for Lung Cancer Patients

2013 04 Apr

The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. Now, for the first time after a decade of biomarker testing in lung cancer, a uniform approach for testing for the EGFR mutation and ALK rearrangement along with the availability of targeted... Read more

Executive Health Management

New Abbott Test Helps Doctors Detect the Presence of Two Important Health Issues

2013 28 Mar

Abbot today announced that the ARCHITECT AFP test, which may help doctors detect serious birth defects and the progression of testicular cancer, received U.S. Food and Drug Administration (FDA) approval.  Biomarkers, such as alpha-fetoprotein (AFP), are substances in the body that physicians can measure to identify the progress of diseases or conditions... Read more

ICU Management

Scientists Eradicate Lung Tumors in a Pre-Clinical Mouse Model

2013 09 Mar

Scientists at the Vall d´Hebron Institute of Oncology (VHIO) in Barcelona, Spain, report that they have eradicated lung tumours in a pre-clinical mouse model. Previous studies had already shown that Myc was a key protein in tumour development and had established how to inhibit Myc through gene therapy. This protein is involved in the development... Read more

IMAGING Management

Screening Could Prevent 12,000 Lung Cancer Deaths a Year in the U.S.

2013 05 Mar

Screening for lung cancer with low-dose computed tomography (LDCT) in current and former smokers eligible for screening could avert approximately 12,000 lung cancer deaths each year in the United States, concludes  a new analysis published online in CANCER, a peer-reviewed journal of the American Cancer Society. By providing a national estimate of... Read more